Last edition
News about "clinical study"
Thryv Therapeutics Initiates Wave II Phase II/III Trial for Long QT Syndrome Type 2
Thryv Therapeutics has launched the Wave II Phase II/III trial to evaluate THRV-1268, an oral SGK1 inhibitor, as a potential disease-modifying therapy for adults with Long QT Syndrome Type 2.
Clinical Study | 14/01/2026 | By News Bureau
Mercy Joins REACH Study to Evaluate GRAIL Galleri Test in Medicare Population
The three year clinical study will assess real-world impact of multi-cancer early detection testing among up to 50,000 Medicare beneficiaries.
Clinical Study | 09/01/2026 | By News Bureau | 101
NeuExcell Therapeutics Hits New Milestone in Treatment of Malignant Glioma with NXL-004
NeuExcell Therapeutics has successfully given the dosing of the first patient with the first-in-class NeuroD1 gene therapy product NXL-004.
Clinical Study | 22/03/2024 | By Manvi | 387
Anti-Tigit drug of Roche fails stage study
Roche's Genentech had disappointing news to share this week regarding its lung cancer hopeful.
Clinical Study | 26/04/2022 | By Sudeep Soparkar | 789
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy